Evidence map›Paper›PMID 42056076›Full record

ArticleBlood cancer journal2026

Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort.

Hossam M Ali, Sandra Mazzoni, Utkarsh Goel, Jack Khouri, Faiz Anwer, Louis S Williams, Diana Basali, Christy J Samaras, Beth M Faiman, Willem Van Heeckeren and 12 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Hossam M Ali *Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0009-0006-3778-5499
Sandra Mazzoni *Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Utkarsh GoelDepartment of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0003-1663-0325
Jack KhouriDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-2473-6528
Faiz AnwerDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-6914-7439
Louis S WilliamsDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Diana BasaliDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Christy J SamarasDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Beth M FaimanDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-8153-0438
Willem Van HeeckerenDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Kimberly HamiltonDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Joslyn RudoniDepartment of Pharmacy, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Mikhaila RiceDepartment of Pharmacy, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-4273-5780
Jonathan KissamDepartment of Pharmacy, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Cynthia ScottDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Saveta MathurDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Alexandra McDonaldDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Tara RoyDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Julie BevacquaDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Marcelo C PasquiniDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Jason ValentDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Shahzad RazaDepartment of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA. razas@ccf.org.ORCID http://orcid.org/0000-0002-2739-2265

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42056076
PMCPMC13128851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.